Article Type
Changed
Tue, 05/03/2022 - 15:22
Display Headline
Addressing Unmet Needs With Injectable Medications in Type 2 Diabetes Treatment

Click Here to Read the Supplement.

Topics include:

  • Medications for Type 2 Diabetes Mellitus: A Work in Progress
  • Role of Injectable Medications in Type 2 Diabetes Treatment
  • Basal Insulins
  • Glucagon-Like Peptide-1 Receptor Agonists
  • Using Combinations of a Basal Insulin and a Glucagon-Like Peptide-1 Receptor Agonist

Click Here to Read the Supplement.

Sponsor
Issue
The Journal of Family Practice - 66(10)
Publications
Topics
Sections
Sponsor
Sponsor

Click Here to Read the Supplement.

Topics include:

  • Medications for Type 2 Diabetes Mellitus: A Work in Progress
  • Role of Injectable Medications in Type 2 Diabetes Treatment
  • Basal Insulins
  • Glucagon-Like Peptide-1 Receptor Agonists
  • Using Combinations of a Basal Insulin and a Glucagon-Like Peptide-1 Receptor Agonist

Click Here to Read the Supplement.

Click Here to Read the Supplement.

Topics include:

  • Medications for Type 2 Diabetes Mellitus: A Work in Progress
  • Role of Injectable Medications in Type 2 Diabetes Treatment
  • Basal Insulins
  • Glucagon-Like Peptide-1 Receptor Agonists
  • Using Combinations of a Basal Insulin and a Glucagon-Like Peptide-1 Receptor Agonist

Click Here to Read the Supplement.

Issue
The Journal of Family Practice - 66(10)
Issue
The Journal of Family Practice - 66(10)
Publications
Publications
Topics
Article Type
Display Headline
Addressing Unmet Needs With Injectable Medications in Type 2 Diabetes Treatment
Display Headline
Addressing Unmet Needs With Injectable Medications in Type 2 Diabetes Treatment
Sections
Disallow All Ads
Content Gating
No Gating (article Unlocked/Free)
Alternative CME
Disqus Comments
Default
Use ProPublica